Physician profile
Charles E Thompson
NPI 1922348440
$14,732.11
in general payments reported to CMS, 2019-2025
24 companies · $35.40 in 2025
The $35.40 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,630 · 2020: $281 · 2021: $4,486 · 2022: $5,460 · 2023: $575 · 2024: $2,264 · 2025: $35.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Travel and Lodging: $1,119 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.00 |
| Travel and Lodging | $1,118.51 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,525.71 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,197.82 | 2021-2024 | Signia, Ligasure |
| Standard Bariatrics, INC. | $599.78 | 2022 | |
| Organogenesis INC. | $213.64 | 2019-2020 | |
| Baxter Healthcare | $165.17 | 2019-2021 | |
| Hologic Sales and Service, LLC | $157.32 | 2023-2024 | Trident Specimen Radiography System, Localizer, Trunode |
| Acell, INC. | $149.14 | 2019 | |
| Coloplast Corp | $125.64 | 2022 | |
| Integra Lifesciences Corporation | $84.55 | 2020-2024 | Integra, Surgimend, Omnigraft |
| Endo Pharmaceuticals INC. | $76.63 | 2019-2020 | |
| Misonix INC | $65.18 | 2019-2020 | |
| Boston Scientific Corporation | $46.74 | 2021-2023 | Apollo Esg System |
| Takeda Pharmaceuticals U.S.A., INC. | $43.73 | 2021-2024 | Eohilia |
| Cumberland Pharmaceuticals, INC. | $41.79 | 2019-2020 | |
| Vivus LLC | $40.68 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28.52 | 2020 | |
| Tela Bio, INC. | $28.05 | 2019 | |
| Teleflex LLC | $24.75 | 2023 | Titan Sgs Standard Gastric Stapler |
| Kci USA, INC. | $24.23 | 2019 | |
| Intra-Sana Laboratories | $23.20 | 2021 | |
| Aroa Biosurgery Incorporated | $18.71 | 2020 | |
| Lilly USA, LLC | $18.64 | 2025 | Zepbound, Mounjaro |
| Currax Pharmaceuticals LLC | $16.76 | 2025 | Contrave |
| Tactile Systems Technology INC | $15.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.